# US 2013/0158269 A1 · (aza)indole derivative substituted in position 5, pharmaceutical composition comprising it, intermediate compounds and preparation process therefor

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2013/0158269 A1
- Document ID: US20130158269A1
- Status: Published application
- Kind: A1
- Application number: 13/768,013
- Filed: 2013-02-15
- Published: 2013-06-20
- Earliest claimed: 2007-12-28
- Assignees: Aziende Chimiche Riunite Angelin Francesco A.C.R.A.F. S.P.A.
- Inventors: Maria Alessandra Alisi; Guido Furlotti; Nicola Cazzolla; Caterina Maugeri; Patrizia Dragone; Barbara Garofalo; Isabella Coletta; Giorgina Mangano; Beatrice Garrone
- Web page: https://patentgrep.com/patent/US20130158269A1

## CPC

- C07D 471/04: Ortho-condensed systems
- A61P 9/10: for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A61P 19/02: for joint disorders, e.g. arthritis, arthrosis
- A61P 25/00: Drugs for disorders of the nervous system
- A61P 29/00: Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P 35/00: Antineoplastic agents
- A61P 43/00: Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C07D 209/08: with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
- C07D 209/10: with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D 209/12: Radicals substituted by oxygen atoms
- C07D 209/18: Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D 209/42: Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D 401/04: directly linked by a ring-member-to-ring-member bond
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

An (aza)indole derivative substituted in position 5, of formula (I) in which X, Y, Z, G1, G2, G3, R1, W, and R2 have the meanings given in the description, a pharmaceutical composition comprising it, and also intermediate compounds and a preparation process therefor.

## Claims

### Claim at position 1

1-25. (canceled)

### Claim 26

An intermediate compound represented by formula (III)
wherein
G1, G2, and G3, which may be identical or different, are a nitrogen atom or a CH group;
R1 is a (C1-C6)alkyl, (C3-C7)cycloalkyl, (C1-C6)alkylORI, (CH2)CONRIIRIII, (CH2)nCORI, (CH2)nCOORII, (CH2)nOCORI, SO2RI, (CH2)nNRIISO2RI, or (CH2)nSO2RI group, optionally substituted with 1 to 3 hydroxy groups, wherein n is an integer from 1 to 6, RI is a (C1-C3)alkyl, or (C1-C3)alkylOH group, and RII and RIII, which may be identical or different, are a hydrogen atom or a (C1-C3)alkyl group;
W is a σ bond, or a (C1-C6)alkyl, (C2-C6)alkenyl, O(C1-C6)alkyl, O(C2-C6)alkenyl, C(O)NH, (CH2)pCO(CH2)qi or (CH2)pC(OH)(CH2)q group, wherein p and q, which may be identical or different, are an integer from 0 to 3; and
R2 is a phenyl, pyridyl, or (C4-C7)cycloalkyl group, optionally substituted with 1 to 3 substituents, which may be identical or different, represented by L-M-, wherein L is a σ bond, or a (C1-C6)alkyl, (C2-C6)alkenyl, (C2-C6)alkinyl, O(C1-C6)alkyl, O(C2-C3)alkenyl, or O(C2-C6)alkinyl group, and M is a hydrogen or halogen atom, or a OH, CF3, NO2, CN, COORII, SO2NHRII, CH2CONRIIRIII, NRIIRIII, SO2RIV, NHSO2RIV, PORIVRV, or OPORIVRV group, wherein RII and RIII, which may be identical or different, have the meaning above, and RIV and RV, which may be identical or different, are a (C1-C3)alkyl group,
provided that
when G1, G2, and G3 are all a CH group, R1 is a (C1-C6)alkyl or (C3-C7)cycloalkyl group, optionally substituted with 1 to 3 hydroxy groups, W is a σ bond, and the bond between the carbon atoms in the 2 and 3 position is a double bond, then
R2 is not a phenyl or pyridyl group, optionally substituted with 1 to 3 substituents, which may be identical or different, selected from the group consisting of a halogen, (C1-C6)alkyl optionally substituted with a hydroxy group, trifluoromethyl, nitro, amino, di(C1-C3)alkylamino, hydroxy, (C1-C3)alkoxy, COOH, COORII, SO2CH3, SO2NHCH3, NHSO2CH3, PORIVRV, OPORIVRV, (C1-C6)alkyl-COOH, and (C2-C6)alkenyl-COOH;
and provided that
when G1 is N, and G2 and G3 are a CH group, then
R2 is not a divalent aromatic group substituted with one L-M group represented by O(C1-C6)alkyl, O(C2-C6)alkenyl, or O(C2-C6)alkinyl group.

### Claim 27 (depends on 26)

An intermediate compound according to claim 26, wherein R1 is:
a (C1-C3)alkyl, (C1-C3)alkylORI, (CH2)nNRIIRIII, (CH2)nCONRIIRIII, (CH2)nCORI, (CH2)nCOORII, (CH2)nOCORI, SO2RI, (CH2)nNRIISO2RI, or (CH2)nSO2RI group, optionally substituted with 1 to 3 hydroxy groups, wherein n is an integer from 1 to 4, RI is a (C1-C3)alkyl or (C1-C3)alkylOH group, and RII and RIII, which may be identical or different, are a hydrogen atom or a (C1-C3)alkyl group; or
a (C1-C3)alkyl, (C1-C3alkylORI, (CH2)nCONRIIRIII, (CH2)nCORI, (CH2)nCOORII, (CH2)nOCORI, SO2RI, (CH2)nNRIISO2RI, or (CH2)nSO2RI group, optionally substituted with 1 to 3 hydroxy groups, wherein n is an integer from 1 to 3, RI is a CH3, C2H5, CH2OH, a C2H4OH group, and RII and RIII, which may be identical or different, are a hydrogen atom or a CH3, C2H5 group.

### Claim 28 (depends on 26)

An intermediate compound according to claim 26, wherein W is:
a σ bond, a (C1-C3)alkyl, (C1-C4)alkenyl, O(C1-C3)alkyl, O(C2-C3)alkenyl, C(O)NH, (CH2)pCO(CH2)q, or (CH2)pC(OH)(CH2)q group, wherein p and q, which may be identical or different, are an integer from 1 to 3; or
a σ bond, a CH2, C2H4, CH═CH, OCH2, OC2H4, OCH═CH, C(O)NH, (CH2)pCO(CH2)q, or (CH2)pC(OH)(CH2)q group, wherein p and q, which may be identical or different, are an integer from 1 to 2.

### Claim 29 (depends on 26)

An intermediate compound according to claim 26, wherein R2 is:
a phenyl, pyridyl, or (C3-C7)cycloalkyl group, optionally substituted with 1 to 2 substituents, which may be identical or different, represented by an L-M, wherein L is a σ bond, or a (C1-C3)alkyl, (C1-C4)alkenyl, (C1-C4)alkinyl, O(C13)alkyl, O(C1-C4)alkenyl, or O(C1-C4)alkinyl group, and M is a hydrogen or halogen atom, or a CF3, CN, COORII, SO2NHRII, CH2CONRIIRIII, NRIIRIII, SO2RIV, NHSO2RIV, PORIVRV, or OPORIVRV group, wherein RII and RIII, which may be identical or different, are a hydrogen atom or a (C1-C3)alkyl group, and RIV and RV, which may be identical or different, are a (C1-C3)alkyl group; or
a phenyl, pyridyl, or (C3-C7)cycloalkyl group, optionally substituted with 1 substituent represented by an L-M, wherein L is a σ bond, or a CH2, C2H4, CH═CH, C≡C, OCH2, OC2H4, OCH═CH, OC≡C group, and M is a hydrogen or halogen atom, or a CF3, CN, COORII, SO2NHRII, CH2CONRIIRIII, NRIIRIII, SO2RIV, NHSO2RIV, PORIVRV, or OPORIVRV group, wherein RII and RIII, which may be identical or different, are a hydrogen atom or a CH3, C2H5 group, and RIV and RV, which may be identical or different, are a CH3 or C2H5 group.

### Claim 30 (depends on 26)

An intermediate compound according to claim 26, wherein W is a σ bond, or a CH2 or C2H4 group; and
R2 is a phenyl group optionally substituted with 1 to 3 substituents, which may be identical or different, selected from the group consisting of Br, Cl, F, CH3, C2H5, OCH3, OC2H5, CN, CH2CN, and CH2CONH2;
a cyclohexyl group optionally substituted with 1 to 3 substituents, which may be identical or different, selected from the group consisting of Br, Cl, F, CH3, C2H5, OCH3, OC2H5, CN, CH2CN, and CH2CONH2; or
a pyridyl group optionally substituted with 1 to 3 substituents, which may be identical or different, selected from the group consisting of Br, Cl, F, CH3, C2H5 OCH3, OC2H5, CN, CH2CN, and CH2CONH2.

### Claim 31

(canceled)
